Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant genes (Expand Search)
significant main » significant gap (Expand Search), significant amount (Expand Search), significant cause (Expand Search)
Showing 2,721 - 2,740 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant main) OR (significant green)) decrease ))', query time: 0.45s Refine Results
  1. 2721
    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DALYs from 1990 to 2019; (c) The change in DALYs cases between 1990 and 2019. DALYs disability-adjusted life years, EAPC estimated annual percentage change, LRI lower respiratory infections.

    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DA... by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2722
    Global and national estimates of disability-adjusted life years (DALYs) due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021.

    Global and national estimates of disability-adjusted life years (DALYs) due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2723
    DALYs rate and SDI across all regions between1990 and 2021 (a). DALYs rate across all countries in 2021 by SDI (b). DALYs disability-adjusted life years, SDI socio-demographic index.

    DALYs rate and SDI across all regions between1990 and 2021 (a). DALYs rate across all countries in 2021 by SDI (b). DALYs disability-adjusted life years, SDI socio-demographic inde... by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2724
    The number and ASR of deaths for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021.

    The number and ASR of deaths for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2725
    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of deaths from 1990 to 2019; (c) The change in death cases between 1990 and 2019. EAPC estimated annual percentage change, LRI lower respiratory infections.

    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2726
    The number and ASR of DALYs for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021.

    The number and ASR of DALYs for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2727
    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
    Save to List
    Saved in:
  8. 2728
    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
    Save to List
    Saved in:
  9. 2729
    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
    Save to List
    Saved in:
  10. 2730
    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
    Save to List
    Saved in:
  11. 2731
    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”
    Save to List
    Saved in:
  12. 2732
    Sex-specific and age-specific crude cumulative incidence and rate ratio of hemorrhagic stroke and CVST during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods.

    Sex-specific and age-specific crude cumulative incidence and rate ratio of hemorrhagic stroke and CVST during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods. by Soo Hyeon Cho (19797394)

    Published 2024
    Save to List
    Saved in:
  13. 2733
    Summary of time-series correlation analyses between hemorrhagic stroke & CVST and known risk factors during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods.

    Summary of time-series correlation analyses between hemorrhagic stroke & CVST and known risk factors during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods. by Soo Hyeon Cho (19797394)

    Published 2024
    Save to List
    Saved in:
  14. 2734
    NbUCH positive regulates RipE1 accumulation in <i>N. benthamiana.</i>

    NbUCH positive regulates RipE1 accumulation in <i>N. benthamiana.</i> by Wenjia Yu (9422059)

    Published 2025
    Save to List
    Saved in:
  15. 2735
    Key characteristics of non-healed DU wound records at adopted branches in 2022 and 2023.

    Key characteristics of non-healed DU wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2736
    Overall characteristics of wound records at adopted branches in 2022 and 2023.

    Overall characteristics of wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2737
    Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for access question between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues and c) Urban/Rural Class.

    Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for access question between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues and c... by David Henderson (4612354)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2738
    Primer sequences for qPCR.

    Primer sequences for qPCR. by Tucker Hopkins (20790529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2739
    The constitutively active form of insulin receptor and knockdown of FoxO block high temperature-mediated body fat loss.

    The constitutively active form of insulin receptor and knockdown of FoxO block high temperature-mediated body fat loss. by Tucker Hopkins (20790529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2740
    FDA-approved reference marker and capturing wound image.

    FDA-approved reference marker and capturing wound image. by Heba Tallah Mohammed (2822432)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: